Rizo Aleksandra 4
4 · Syndax Pharmaceuticals Inc · Filed May 16, 2024
Insider Transaction Report
Form 4
Rizo Aleksandra
Director
Transactions
- Award
Stock Options (Right to buy)
2024-05-15+35,000→ 35,000 totalExercise: $21.94Exp: 2034-05-15→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option shall vest monthly over a three-year period.